Correction To: Atherothrombosis Prevention and Treatment With Anti-Interleukin-1 Agents

Current Atherosclerosis Reports - United States
doi 10.1007/s11883-020-0827-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Anti-Interleukin-1 Agents in Adult Onset Still's Disease

International Journal of Inflammation
AllergyImmunology
2012English

PReS-FINAL-1005: Hypertransaminasemia in Systemic Juvenile Idiopathic Arthritis During Anti-Interleukin 1 Treatment

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2013English

International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis

JAMA - Journal of the American Medical Association
Medicine
2006English

Inhibition of Interleukin-1 Responsiveness by Type II Receptor Gene Transfer: A Surface "Receptor" With Anti-Interleukin-1 Function

Journal of Experimental Medicine
MedicineAllergyImmunology
1996English

Correction to ‘ ALOX5, LPA, MMP9 and TPO Gene Polymorphisms Increase Atherothrombosis Susceptibility in Middle-Aged Mexicans’

Royal Society Open Science
Multidisciplinary
2020English

New Possibilities in the Treatment of Patients With Stable Manifestations of Atherothrombosis

Kardiologiya
Cardiovascular MedicineCardiology
2017English

Interleukin-1, Interleukin-1 Receptor, and Interleukin-1 Receptor Antagonist

Proceedings of the Nutrition Society
MedicineNutritionDietetics
1994English

Anti-Interleukin 6 Receptor Antibody Treatment in Rheumatic Disease

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2000English

Potential of Immunomodulatory Agents for Prevention and Treatment of Neonatal Sepsis

Journal of Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy